G1 Therapeutics to Provide Fourth Quarter and Full Year 2020 Financial Results and Business Update on February 24, 2021

NEXT STORY
SCYNEXIS Announces Licensing Agreement and Strategic Partnership with Hansoh Pharma for Rights to Ibrexafungerp in Greater China
PREV STORY
Global Blood Culture Tests Market (2020 to 2025) – Identification of Antibiotic-Resistant Microorganisms Presents Opportunities
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Principia Biopharma to Present at 27th Annual Credit Suisse Healthcare Conference

SOUTH SAN FRANCISCO, Calif., Nov. 08, 2018 (GLOBE NEWSWIRE) -- Principia Biopharma Inc. (Nasdaq: ...

author_avatar
NASDAQ Market News

Global Viral Vector Manufacturing Market Outlook to 2026 – Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and Recommendations

author_avatar
NASDAQ Market News

BioSig’s Division NeuroClear Technologies Signs a Research Agreement with the University of Minnesota

author_avatar
NASDAQ Market News